KACTUS
Vincent Wu has a diverse work experience spanning over several companies and roles. Vincent is currently serving as the Vice President of US Operations at KACTUS since January 2022. Prior to this, they worked at HUABIO as an Executive Advisor from April 2022 to June 2023 and as the Chief Executive Officer from July 2020 to March 2022. Vincent also has experience at Bioss Inc., where they worked as the Chief Executive Officer from July 2019 to June 2020, General Manager from July 2015 to June 2019, Director of Marketing and Business Development from July 2013 to June 2015, and Sales Manager from July 2011 to June 2013. Additionally, they worked as a Research Scientist at Link Medicine from November 2010 to May 2011 and as a Research Assistant at The Pennsylvania State University from August 2007 to May 2010, where they focused on studying the cell signaling pathway of retinoic acid.
Vincent Wu completed their Master of Business Administration - MBA degree from Babson College, from 2016 to 2018. Prior to that, they pursued their Master of Science - MS degree in Immunology, Biochemistry, and Nutritional Sciences from Penn State University, from 2007 to 2010.
This person is not in any teams
KACTUS
KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC complexes, GPCR, CD20, and highly bioactive mRNA capping enzymes. Our goal is to deliver first-to-market innovative protein and antibody products. We also offer custom protein production including both research-grade and GMP-grade material. SAMS™ Technology Platform Our proprietary Structure Aided Design & Multiplex Screening (SAMS™) platform uses bioinformatics and 3D modeling to create vast search spaces for protein configurations. Expression conditions are optimized in vitro to identify settings that produce a natural protein configuration with bioactivity in multiple cell lines/settings. Quality KACTUS performs strict quality control testing on all our products including endotoxin levels. We also have facilities compatible with U.S. FDA cGMP guidelines to produce GMP-grade material. Our GMP-level partnerships are designed to provide you with routine bulk supply of material and supporting documentation to bring you from the R&D stage to commercial manufacturing and regulatory submission. In addition, our SAMS™ platform will assist in custom scientific optimization of your reagent.